Biodesix Inc Cash Flow Statement

Cash Flow Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -29.69M-30.52M-45.45M-58.66M-50.88M-42.76M
Depreciation and Depletion 0.82M0.84M1.23M1.62M1.34M3.77M
Share-based Compensation 0.17M3.71M4.94M5.96M5.37M6.64M
Gains from Sales and Divestitures 0.36M0.71M0.61M
Gains from Investment Securities 1.92M2.32M2.88M2.54M2.04M4.16M
Asset Writedowns and Impairment 0.25M0.30M0.19M0.91M0.20M0.24M
Non-cash Items 1.19M6.29M1.52M1.30M1.86M
Cash from Operations -21.73M-21.37M-28.22M-44.97M-22.87M-48.65M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.26M4.39M2.25M2.18M
Amortization of Deferred Charges 0.14M0.14M
Depreciation & Amortization (CF) 2.79M2.90M3.18M3.60M3.33M5.77M
Change in Working Capital
Change in Receivables 3.65M10.31M-11.45M1.50M4.72M1.81M
Change in Accured Expenses 1.19M11.65M-7.42M-0.77M0.51M1.64M
Other Working Capital Changes 0.79M6.59M-1.68M-1.21M-0.91M-0.72M
Investing Activities
Capital Expenditures 1.31M1.95M2.24M3.30M22.92M3.23M
Cash from Investing Activities -1.87M-2.93M-2.55M-3.53M-23.06M-3.44M
Financing Activities
Other financing activities -0.12M8.24M0.66M3.73M0.83M-0.45M
Cash from Financing Activities 22.97M81.13M1.26M58.88M29.13M52.05M
Additional items
Change in Cash -0.63M56.84M-29.51M10.38M-16.80M-0.04M
Free Cash Flow -23.04M-23.31M-30.46M-48.27M-45.79M-51.88M
Net Cash Flow -0.63M56.84M-29.51M10.38M-16.80M-0.04M